TABLE 3.
Liver fatty acid profiles of control (n = 4) and diabetic (n = 7) animals
| Fatty acids | Liver |
P | ||
|---|---|---|---|---|
| Control animals | Diabetic animals | Difference | ||
| Total (nmol/mg protein) | 1,762.82 ± 480.50 | 1,357.85 ± 241.19 | 0.1,542 | |
| Mole % of total fatty acids | ||||
| 16:0 (palmitic) | 26.73 ± 8.18 | 17.55 ± 3.25 | 0.0518 | |
| 18:0 (stearic) | 11.25 ± 3.74 | 12.64 ± 3.55 | 0.9706 | |
| 18:1n9 (oleic) | 3.11 ± 1.03 | 3.39 ± 1.04 | 0.4785 | |
| 18:2n6 (linoleic) | 33.14 ± 5.34 | 39.90 ± 2.71 | ↑ | 0.0161* |
| 18:3n3 (α-linolenic) | 0.49 ± 0.11 | 0.59 ± 0.11 | 0.2101 | |
| 18:3n6 (γ-linolenic) | 0.13 ± 0.14 | 0.09 ± 0.04 | 0.2173 | |
| 20:3n6 (dihomo-γ-linolenic) | 0.34 ± 0.04 | 0.43 ± 0.15 | 0.3942 | |
| 20:3n9 (mead) | 0.62 ± 0.24 | 0.51 ± 0.14 | 0.9340 | |
| 20:4n6 (arachidonic) | 19.87 ± 4.43 | 21.37 ± 2.50 | 0.4581 | |
| 20:5n3 (eicosapentaenoic) | 0.15 ± 0.03 | 0.15 ± 0.05 | 0.7777 | |
| 22:5n3 (docosapentaenoic) | 0.57 ± 0.15 | 0.44 ± 0.07 | 0.2388 | |
| 22:6n3 (docosahexaenoic) | 3.60 ± 0.92 | 2.94 ± 0.35 | 0.2294 | |
| Fatty acid ratios | ||||
| Unsaturation index | 5.05 ± 1.82 | 6.56 ± 1.31 | 0.0911 | |
| LCPUFA/SCPUFA† | 0.74 ± 0.07 | 0.64 ± 0.02 | ↓ | 0.0123* |
| 20:4n6/18:2n6 | 0.60 ± 0.07 | 0.53 ± 0.03 | 0.1211 | |
| 22:6n3/18:3n3 | 7.74 ± 2.96 | 5.11 ± 1.05 | 0.0979 | |
Data are means ± SD.
*P < 0.05.
†Long-chain PUFAs/short-chain PUFAs.